Original Webinar Date: 06/29/2021

Tumor-Normal Matched Sequencing and Platforms Utilized for Tumor Profiling

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 2
Speakers Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

ep2 onclive preview image

Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.

Watch the Webinar Here

Related
Webinars

View more
  • image description
    06/29/2021
    UPCOMING WEBINAR:

    Operational Processes and Challenges

    Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

    Watch replay
  • image description
    06/29/2021
    UPCOMING WEBINAR:

    Role of ctDNA in Germline Testing

    Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

    Watch replay
  • image description
    06/29/2021
    UPCOMING WEBINAR:

    Identification of Patients for Germline Testing

    Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

    Watch replay